期刊文献+

非病毒基因载体材料聚谷氨酸-聚丙烯亚胺的合成及与DNA的结合稳定性 被引量:1

Synthesis of Nonviral Gene Carrier Poly( L-glutamic acid)-graft-Polypropylenimine and Its Complexation Stability with DNA
原文传递
导出
摘要 目的合成非病毒基因载体材料聚谷氨酸-聚丙烯亚胺,并考查其与DNA的结合能力及稳定性。方法以G2.0聚丙烯亚胺(PPI)为引发剂,通过开环聚合的方法,合成了聚丙烯亚胺-聚谷氨酸苄脂多臂接枝聚合物,再以G1.0聚丙烯亚胺或G2.0聚丙烯亚胺作为氨解试剂进行氨解合成了新型树枝状的聚谷氨酸-聚丙烯亚胺聚合物(MP-g-PPI)。采用红外光谱(IR)、1HNMR对聚合产物进行结构表征,通过琼脂糖凝胶电泳实验考察聚合物与DNA的结合能力,通过离心法考察了聚合物与DNA形成复合物的沉淀稳定性,通过MTT法考察聚合物在Hela细胞中的毒性,并通过测定发荧光细胞百分数获得复合物在Hek-293细胞中的转染率。结果成功合成了聚谷氨酸-聚丙烯亚胺聚合物,此聚合物可有效的与DNA结合成纳米复合物,可通过一定的空间斥力阻止复合物的聚集,且毒性较PEI 25K低,可有效介导基因的转染。结论聚谷氨酸-聚丙烯亚胺聚合物可与DNA形成稳定的复合物,此聚合物有望成为新型的非病毒基因载体材料。 OBJECTIVE To synthesize nonviral gene carrier poly (L-glutamic acid) -graft-polypropylenimine (MP-g-PPI) and investigate the capability of the polymers to condense DNA and the stability of MP-g-PPI DNA complexes. METHODS A series of new multi-armed MP-g-PPI polymers were synthesized by ring-opening polymerization using G2. 0PPI as macromolecular initiator and subsequent aminolysis with G1.0PPI or G2.0PPI. The new synthetic polymers were characterized by IR and 1H-NMR. The capability of the polymers to condense DNA was evaluated by agarose gel electrophoresis, and the sedimentation stability of the complexes was also in- vestigated by centrifugal method. The transfection efficiency in Hek-293 ceils was evaluated by measuring the percentage of cells expressing green fluorecensce protein. RESULTS The MP-g-PPI polymers were successfully synthesized. The polymers could effectively condense DNA to form nanoparticles, and provide efficient steric repulsion to prevent the complexes from aggregation. Meanwhile, the polymers could effectively transfer the gene vectors. CONCLUSION The MP-g-PPI polymers can form stable complexes with DNA, and thus may be potential candidates as nonviral gene carriers.
出处 《中国药学杂志》 CAS CSCD 北大核心 2014年第22期2002-2007,共6页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(31100683 31000429)
关键词 聚丙烯亚胺 聚谷氨酸-聚丙烯亚胺聚合物 基因载体 琼脂糖凝胶电泳 沉淀稳定性 转染 polypropylenimine MP-g-PPI polymer gene vector agarose gel electrophoresis sedimentation stability transfection
  • 相关文献

参考文献15

  • 1SMITH D K. Dendrimers and the double Helix-From DNA binding towards gene therapy[J]. Curr Top Med Chem, 2008, 8(14):1187-1203.
  • 2KLINGLER J, KAUFMANN D. Polypropylenimine generation four: A suitable vector for targeted gene alteration in vitro [J]. J Drug Target, 2012, 20(5):474-480.
  • 3SMITH D K. Dendrimers and the double Helix-From DNA binding towards gene therapy [J]. Curr Top Med Chem, 2008, 8(14):1187-1203.
  • 4ZINSELMEYER B H, MACKAY S P, SCHATZLEIN A G, et al. The lower-generation polypropyleneimine dendrimers are effective gene-transfer agents [J]. Pharm Res, 2002, 19(7):960-967.
  • 5TACK F, BAKKER A, MAES S, et al. Dendrimeric poly(propylene-imines) as effective delivery agents for DNAzymes: Toxicity, in vitro transfection and in vivo delivery [J]. J Controlled Release, 2006, 116(2):26-28.
  • 6HAO J, SHA X, TANG Y, et al. Enhanced transfection of polyplexes based on pluronic-polypropylenimine dendrimer for gene transfer [J]. Arch Pharm Res, 2009, 32(7):1045-1054.
  • 7KOPPU S, OH Y J, EDRADA-EBEL R, et al. Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA[J]. J Controlled Release, 2010, 143(2):215-221.
  • 8TARATULA O, GARBUZENKO O B, KIRKPATRICK P, et al. Surface-engineered targeted PPI dendrimer for efficient intracellular and intratumoral siRNA delivery [J]. J Controlled Release, 2009, 140(3):284-293.
  • 9CHEN L, TIAN H, CHEN J, et al. Multi-armed poly(L-glutamic acid)-graft-oligoethylenimine copolymers as efficient nonviral gene delivery vectors [J]. J Gene Med, 2010, 12(1):64-76.
  • 10PAN S, CAO D, YI W, et al. A biodegradable and serum-resistant gene delivery carrier composed of polyamidoamine-poly N,N′-di-(2-aminoethyl) aminoethyl glutamine copolymer[J]. Colloids Surf B Biointerfaces, 2013, 104(1):294-302.

二级参考文献12

  • 1PANDITA D, SANTOS J L, RODRIGUES J, et al. Gene delivery into mesenehymal stem cells: a biomimetie approach using RGD nanoclusters based on poly (amidoamine) dendrimers [ J ]. Biomacromolecules, 2011,12 ( 2 ) : 472 - 481.
  • 2LIU Y, REINEKE T M. Degradation of poly ( glycoamidoamine) DNA delivery vehicles: polyamide hydrolysis at physiological conditions promotes DNA release[ J]. Biomacromolecules,2010,11 (2) :316 - 325.
  • 3SMITH D K. Dendrimers and the double helix -from DNA binding towards gene therapy [ J ]. Curt Top Med Chem, 2008, 8 (14) : 1187 - 1203.
  • 4KLINGLER J, KAUFMANN D. Polypropylenimine generation four: a suitable vector for targeted gene alteration in vitro[J]. J Drug Target, 2012, 20(5) :474 -480.
  • 5ZINSELMEYER B H, MACKAY S P, SCHATZLEIN A G, et al. The lower-generation polypropyleneimine den- drimers are effective gene-transfer agents [ J ]. Pharm Res, 2002, 19(7) :960-967.
  • 6KOPPU S, OH Y J, EDRADA-EBEL R, et al. Tumor regression after systemic administration of a novel tumortargeted gene delivery system carrying a therapeutic plasmid DNA[ J]. J Control Release, 2010,143 (2) : 215 - 221.
  • 7RUSS V, GUNTHER M, HALAMA A, et al. Oligoethylenimine-grafted polypropylenimine dendrimers as degrad- able and biocompatible synthetic vectors for gene delivery [J]. J Control Release, 2008,132(2):131 -140.
  • 8TARATULA O, GARBUZENKO O B, KIRKPATRICK P, et al. Surface-engineered targeted PPI dendrimer for efficient intraeellular and intratumoral siRNA delivery [-]. J Control Release, 2009,140(3):284 -293.
  • 9TOMALIA D A. Birth of a new macromolecular architecture: dendrimers as quantized building blocks for nanoscale synthetic polymer chemistry [ J ]. Prog Polym Sci, 2005,30(3/4) :294 -324.
  • 10RUSS V, ELFBERG H, THOMA C, et al. Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer [ J ]. Gene Ther, 2008,15( 1 ) :18 -29.

同被引文献14

  • 1RAFII MS, AISEN PS. Advances in Alzheimer's disease drug de- velopment[J]. BMCMed, 2015, 13(62):1-7.
  • 2NGUYEN JT, YAMANI A, KISO Y. Views on amyloid hypothe- sis and secretase inhibitors for treating Alzheimer'sdisease: pro- gress and problems [ J ]. Curt Pharm Des, 2006, 12 (33) : 4295 -4312.
  • 3LULITA MF, ALLARD S, RICHTER L, et al. Intracellular AI3 pathology and early cognitive impairments in a transgenic rat over- expressing human amyloid precursor protein: a multidimensional study[J]. Acta Neuropathol Commun, 2014, 2(-61 ) :1 - 17.
  • 4DEVI L, OHNO M. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice [ J ]. Mol Brain, 2015, 8(1) : 19.
  • 5PAN Q, LIU B, LIU J, et al. Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC[J]. Acta Oncol, 2008,47( 1 ) :135 - 144.
  • 6GUO W, FLANAGAN J, JASUJA R, et al. The effects of myo- statin on adipogenic differentiation of human bone marrow-derived mesenehymal stem cells are mediated through cross-communica- tion between Smad3 and Wnt/beta-catenin signaling pathways [J]. JBiolChem, 2008, 283( 14):9136-9145.
  • 7ZHANG X, HU HM, LIU TB, et al. Multi-armed poly( L-glu- tamic acid)-graft-polypropyleneimine as effective and serum re- sistant gene delivery vectors [ J ]. Int J Pharm, 2014,465 (1 - 2): 444-454.
  • 8HUANG R, HAN L, LI J, et al. Neuroprotection in a 6-hydroxydo- pamine-lesioned Parklnson model using lactoferrin-modified nano- particles[J]. JGeneMed, 2009,11(9):754-763.
  • 9NGUYEN JT, YAMANI A, KISO Y. Views on amyloid hypothe- sis and secretase inhibitors for treating Alzheimer'sdisease: pro- gress and problems [ J ]. Curr Pharm Des, 2006, 12 (33) : 4295 - 4312.
  • 10GONZALEZ-ALEGRE P. Therapeutic RNA interference for neu- rodegenerative diseases:From promise to progress[ J]. Pharmacol Ther, 2007, 114(1) : 34 -55.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部